Compounded vs research peptides.
The same peptide can reach a bench or a clinic by three routes: as an approved drug, as a compounded preparation from a pharmacy, or as a research chemical in a lyophilized vial. The molecule may be identical; the product is not. Here is what each channel is, who is allowed to make it, what it guarantees and why the labels cannot be swapped.
Three channels, one table.
| Approved drug | Made under pharmaceutical manufacturing standards to an FDA-approved application; sold on prescription; labeled for use in people |
|---|---|
| Compounded preparation | Made by a 503A pharmacy for a named patient, or by a 503B outsourcing facility in bulk, from bulk substances the FDA allows; prescription required |
| Research peptide | A laboratory chemical sold as a lyophilized reference material, research use only; identity and purity shown by a lab report; not for human or veterinary use |
The full application.
An approved peptide drug has been through clinical trials and manufacturing review, and every batch is made and released under the standards that apply to drugs. A handful of the peptides in the research literature exist in this form: tesamorelin as a prescription product since 2010, oxytocin, gonadorelin in some formulations, sermorelin until it was withdrawn in 2008. For these the research vial and the drug are the same molecule sold under different rules, as reference standards vs research peptides explains.
503A and 503B.
Compounding pharmacies make preparations that are not available as approved products. A 503A pharmacy compounds for an individual patient on a prescription; a 503B outsourcing facility, registered with the FDA, makes larger batches under its own set of requirements. Both may use only bulk substances that the FDA permits for compounding, which is where the agency's Category 2 list comes in: substances on it may not be compounded. As of the list current in April 2026, that includes GHRP-2, GHRP-6, ipamorelin acetate and kisspeptin-10, while BPC-157, CJC-1295 and a dozen other peptides sit on the page as nominations later withdrawn. The compounded product is a sterile preparation made for human use and dispensed by a pharmacist, and it is regulated as such.
A chemical with a lab report.
A research peptide is sold as a chemical, not as a medicine. It is made by solid-phase synthesis, purified by HPLC and freeze-dried into a sealed vial; an independent laboratory tests the lot for identity, purity and content, and the report is published. What the research channel does not provide is any of the assurance that goes with a drug product: no clinical data for the vial, no release testing for human use and no sterility assurance for administration to a person. That is the substance behind the research-use-only label. Are research peptides legal? covers the law that follows from it.
Why the labels cannot be swapped.
Because the molecule can be identical across all three channels, it is tempting to treat them as grades of one product. They are not. A research vial cannot become a drug by being well tested, and a compounded preparation cannot be sold as a research chemical. Each channel has its own maker, its own rules and its own buyer, and the paperwork that travels with the product, an approval, a prescription or a lab report, is what tells them apart.
Four signs of the research channel.
A lawful research supplier lists the sequence, formula and mass of each compound, publishes a Certificate of Analysis for the lot, labels every product research use only, and says nothing about using the product in people. A site that sells research vials next to instructions for use is selling in the wrong channel. How to choose a peptide supplier lists the checks.
The research channel, documented.
Helion supplies research compounds only: lyophilized reference materials labeled research use only, with a third-party report for each lot in the COA Portal, sold to buyers 21 and older who acknowledge the research-use terms at checkout.
Specs and storage by compound.
Questions (6)
What is the difference between compounded and research peptides?
A compounded peptide is a preparation made by a licensed pharmacy for human use on a prescription; a research peptide is a laboratory chemical sold as a reference material, research use only, with a lab report.
What is a 503A pharmacy?
A pharmacy that compounds a preparation for an individual patient on a prescription. A 503B outsourcing facility makes larger batches under FDA registration.
Can research peptides be compounded?
Compounding uses pharmaceutical bulk substances that the FDA permits, not research vials, and substances on the FDA's Category 2 list may not be compounded at all.
Is a research peptide the same molecule as the drug?
Often yes. Tesamorelin, oxytocin and gonadorelin exist as approved drugs and as research compounds. The product, its maker and its rules differ even when the molecule does not.
Which peptides can no longer be compounded?
As of April 2026, GHRP-2, GHRP-6, ipamorelin acetate and kisspeptin-10 are in the FDA's Category 2; nominations for BPC-157, CJC-1295 and others were withdrawn.
Does Helion sell compounded peptides?
No. Helion sells research compounds only, research use only, with a published lab report per lot.
Published studies (0)
Citations from PubMed for reference. They describe the compound in the literature, not any Helion lot, and nothing here is guidance on use.